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Abstract
Background: It is unclear if thymus-derived glucocorticoids reach sufficient local concentrations
to support normal thymus homeostasis, or if adrenal-derived glucocorticoids from the circulation
are required. Modern approaches to this issue (transgenic mice that under or over express
glucocorticoid receptor in the thymus) have yielded irreconcilably contradictory results, suggesting
fundamental problems with one or more the transgenic mouse strains used. In the present study,
a more direct approach was used, in which mice were adrenalectomized with or without
restoration of circulating corticosterone using timed release pellets. Reversal of the increased
number of thymocytes caused by adrenalectomy following restoration of physiological
corticosterone concentrations would indicate that corticosterone is the major adrenal product
involved in thymic homeostasis.
Results:  A clear relationship was observed between systemic corticosterone concentration,
thymus cell number, and percentage of apoptotic thymocytes. Physiological concentrations of
corticosterone in adrenalectomized mice restored thymus cell number to normal values and
revealed differential sensitivity of thymocyte subpopulations to physiological and stress-inducible
corticosterone concentrations.
Conclusion: This indicates that thymus-derived glucocorticoids are not sufficient to maintain
normal levels of death by neglect in the thymus, but that apoptosis and possibly other mechanisms
induced by physiological, non stress-induced levels of adrenal-derived corticosterone are
responsible for keeping the total number of thymocytes within the normal range.
Background
Although it is clear that elevated concentrations of endog-
enous glucocorticoids can cause apoptosis in the thymus
[1-3], the role of normal concentrations of glucocorticoids
in thymic homeostasis remains controversial [4-7].
Results reported by Ashwell and colleagues suggest gluco-
corticoids are essential at very low concentrations for early
development and survival of thymocytes and that gluco-
corticoids can alter the sensitivity of more mature thymo-
cytes to positive selection, thereby influencing the T cell
receptor repertoire [5]. In addition, there is convincing
evidence that corticosterone is produced in the thymus
and that it acts locally to affect thymocyte development
[8,9]. Therefore, it was surprising when normal cellular
development (including repertoire) was observed until
the time of birth in glucocorticoid receptor knockout mice
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[10]. This raised serious questions about the necessity of
glucocorticoids as a required or permissive agent in
thymic development.
It has also been suggested that glucocorticoids play a role
in homeostasis in the adult thymus by inducing death by
neglect of thymocytes that are neither positively nor neg-
atively selected. This idea has been based on the observa-
tion that the predominant cell type subjected to death by
neglect, CD4+CD8+ non-mature thymocytes, is most sus-
ceptible to elevated concentrations of glucocorticoids
[11]. Recent results indicate that overexpression of gluco-
corticoid receptors (GR) in developing and mature T cells
leads to decreased cell number in the thymus and a
decreased number of T cells in the periphery in adult mice.
In addition, decreased expression of GR is associated with
increased cell number in the thymus [4]. However, results
obtained with knockout or transgenic mice have been
contradictory [4,7,12-14]. For example, one group using
transgenic mice that express anti-sense GR mRNA in the
thymus found increased thymus cellularity [4], whereas
another group using a cre-lox conditional knockout sys-
tem to eliminate glucocorticoid receptor in cells that
express CD4 (including double positive cells) reported no
increase in cellularity [14]. Both groups verified that the
expected decrease in sensitivity to high concentrations of
glucocorticoids occurred in the transgenic mice. Until the
basis for such differences can be determined, it seems rea-
sonable to use an alternate approach that does not alter
the glucocorticoid receptor (except by natural mecha-
nisms relating to glucocorticoid concentration). In addi-
tion, transgenic approaches cannot provide the
concentration-response information for corticosterone
that would be needed to distinguish normal physiological
effects and stress-related effects.
A small number of studies have been reported in which
systemic glucocorticoid concentrations were reduced by
adrenalectomy, leading to increased numbers of cells in
the thymus [15-17]. However, this observation has not
been universal, with one report indicating no increase in
thymus cellularity in adrenalectomized mice [18]. Thus,
confirmation of an adrenalectomy-induced increase in
thymus cellularity would be useful. Even if confirmation
is obtained, it would still be possible that an adrenal prod-
uct other than corticosterone was responsible for
increased cell number in the thymus. However, if corticos-
terone was the major regulator of thymus homeostasis,
restoring corticosterone to physiological levels in adrena-
lectomized mice should return thymus cell number and
subpopulation ratios to normal values. Therefore, this
approach was used in the present study to determine the
role of systemic corticosterone in thymus homeostasis.
The study was designed so the results would also indicate
whether thymus-derived corticosterone is sufficient to
permit normal maintenance of number of cells in each
major subpopulation in the thymus.
If physiological (adrenal-derived) concentrations of corti-
costerone are important in the induction of death by
neglect of thymocytes, it would seem likely that any
increase in cell number in the thymus of adrenalect-
omized mice would be explained mostly by an increase of
CD4+CD8+ cells, which are the predominant cell type sub-
jected to death by neglect [11]. In addition, it has also
been proposed that physiological concentrations of corti-
costerone increase the sensitivity of thymocytes to nega-
tive selection. Preventing this would presumably cause
fewer single positive thymocytes to die, thus increasing
the percentages of these cells in the thymus. It might also
be expected that immature single positive thymocytes
(CD3 low, CD4-CD8+) would be increased, as these cells
have been reported to be particularly sensitive to gluco-
corticoids [19]. If physiological (non-stress) concentra-
tions of corticosterone contribute to the induction of
death by neglect or negative selection, it would be
expected that sub-physiological concentrations of corti-
costerone would decrease apoptosis in the thymus. Fail-
ure to observe these changes in mice with sub-
physiological concentrations of corticosterone would sug-
gest either that thymus-derived corticosterone [8] is suffi-
cient to compensate for loss of systemic (adrenal-derived)
corticosterone or that corticosterone is not directly
involved in these processes under physiological, non-
stress conditions. The studies described here were
designed to directly test these predictions and thus to indi-
rectly evaluate the role of endogenous glucocorticoids in
death by neglect in the thymus. In addition, this study was
designed to distinguish the relative contributions of sys-
temic (mostly adrenal-derived) glucocorticoids and those
produced in the thymus [8]. The use of a dose-response
approach permitted identification of the point on the cor-
ticosterone concentration vs. thymocyte subpopulation
plot that corresponds to a physiological corticosterone
concentration, and it permitted identification of a distinc-
tion between the effects of sub-physiological concentra-
tions of corticosterone and stress-inducible
concentrations.
Results and discussion
Adrenalectomy increases cell number and alters 
subpopulation percentages in the thymus, and this effect is 
inhibited 24 hr after restoration of corticosterone
The results shown in Figure 1 demonstrate that adrenalec-
tomy significantly increases the total number of cells in
the thymus as well as the number of CD4+CD8- and
CD4+CD8+ cells. The number of CD4-CD8+ and CD4-
CD8- cells was also greater in adrenalectomized mice than
in the naive control group, but the difference was not sig-
nificant. This indicates that the number of CD4+CD8- andBMC Immunology 2004, 5:24 http://www.biomedcentral.com/1471-2172/5/24
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Effect of adrenalectomy and restoration of various concentrations of corticosterone on the number of nucleated cells in the  thymus 24 hours after implantation of corticosterone pellets Figure 1
Effect of adrenalectomy and restoration of various concentrations of corticosterone on the number of nucle-
ated cells in the thymus 24 hours after implantation of corticosterone pellets Treatment groups were: Naive, 
untreated; ADX-N, adrenalectomized naive; ADX-P, adrenalectomized with placebo pellet implanted; other groups, adrenalec-
tomized with corticosterone pellets of the indicated size implanted. The thymus was evaluated 24 hours after pellet implanta-
tion (~3–4 weeks after ADX). Group size was 5–12. Values shown are mean ± S.E. obtained by normalizing groups to the 
mean value for the Naive group (defined as 100%). Results shown are pooled from two independent experiments, and groups 
significantly different from the naive group (by ANOVA followed by Dunnett's test) are shown by * (p < 0.05) or ** (p < 0.01).BMC Immunology 2004, 5:24 http://www.biomedcentral.com/1471-2172/5/24
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CD4+CD8+ cells is diminished to a greater extent than
CD4-CD8+ and CD4-CD8- cells by normal, physiological
concentrations of corticosterone. Results for adrenalect-
omized mice were comparable whether a placebo pellet
was implanted or not, indicating that non-adrenal-
derived stress mediators induced by pellet implantation
did not affect cell number. Timed release corticosterone
pellets were used to restore corticosterone in adrenalect-
omized mice, and 0.5 and 1.5 mg pellets had only mini-
mal effects on any subpopulation 24 hours after
implantation of pellets (Figure 1). Pellets containing 2.5
mg of corticosterone returned the number of CD4+CD8-
and CD4+CD8+ cells to near normal values. A pellet con-
taining 5.0 mg of corticosterone significantly decreased
the number of CD4-CD8- and CD4+CD8+ cells as com-
pared to the naive control group, suggesting that CD4-
CD8- and CD4+CD8+ are more sensitive than CD4+CD8-
and CD4-CD8+  cells to stress-inducible corticosterone
concentrations. The greater sensitivity of CD4+CD8+ cells
as compared to the other subpopulations at high corticos-
terone concentrations has prompted an assumption that
these cells are more sensitive to physiological (unstressed)
concentrations of corticosterone. However, this was not
supported by the results presented here. The results in Fig-
ure 1 do indicate that CD4+CD8+ cells increase in number
to a greater extent than CD4-CD8+ or CD4-CD8- cells in
ADX mice, but CD4+CD8- cells increase in number pro-
portionally more than all these other subpopulations in
mice with sub-physiological concentrations of corticoster-
one (ADX groups).
The changes in subpopulation percentages (as opposed to
cell numbers, which are shown in Figure 1) in the thymus
24 hours after implantation of pellets are shown in Figure
2. These results confirm the greater sensitivity of
CD4+CD8+ cells than the other subpopulations to stress-
inducible concentrations of corticosterone (in mice with a
5 mg pellet). The greater sensitivity of CD4-CD8- cells than
CD4-CD8+ and CD4+CD8- cells noted in Figure 1, was also
Figure 2
Effect of adrenalectomy and restoration of various concen- trations of corticosterone on the percentage of cells in the 4  major subpopulations in the thymus 24 hours after implanta- tion of corticosterone pellets Figure 2
Effect of adrenalectomy and restoration of various 
concentrations of corticosterone on the percentage 
of cells in the 4 major subpopulations in the thymus 
24 hours after implantation of corticosterone pellets 
Data from the experiments noted in Figure 1 were analyzed 
for changes in the percentage of each cell type as compared 
to the total number of nucleated cells per thymus. The values 
did not differ significantly between experiments for any sub-
population, so the data were pooled (without normalizing). 
Groups significantly different from the naive group (by 
ANOVA followed by Dunnett's test) are shown by * (p < 
0.05) or ** (p < 0.01).BMC Immunology 2004, 5:24 http://www.biomedcentral.com/1471-2172/5/24
Page 5 of 14
(page number not for citation purposes)
evident in Figure 2 in terms of a lesser increase in percent-
age of the former cell type as compared to the latter cell
types in mice treated with a 5 mg pellet. However, it
should be emphasized that all subpopulations decreased
in absolute number in these mice, so these percentage val-
ues do not reflect increases in the number of cells in these
subpopulations but increases relative to CD4+CD8+ cells,
which are the most abundant and were diminished to the
greatest extent. No significant change in subpopulation
percentages was caused by adrenalectomy with or without
a placebo pellet. However, it should be noted that the
results shown in Figure 1 indicate that the number of
CD4+CD8+  and CD4+CD8-  cells increased to a greater
extent than the number of CD4-CD8- or CD4-CD8+ cells.
This did not result in a substantial change in percentages
(Figure 2), because the cells that increased the most
(CD4+CD8+ cells) account for over 90% of the total thy-
mocyte population, and changes in this subpopulation
were reflected in the denominator (total cell number) of
the equation that determines the percentage of cells in
each population.
Adrenalectomy increases cell number and alters 
subpopulation percentages in the thymus, and this effect is 
inhibited 72 hr after restoration of corticosterone
Changes in the thymus were first evaluated 24 hours after
implantation of pellets to allow determination of the role
of apoptosis in loss of cells at a time point at which cell
numbers were still decreasing. To determine if greater or
different effects were evident after a longer period of cor-
ticosterone exposure, thymuses were evaluated 72 hours
after implantation of pellets. As shown in Figure 3, the
effects on cell number and on the number of cells in most
subpopulations were greater than observed after 24 hours
(Figure 1). For example, mice with a 2.5 mg corticosterone
pellet had significantly fewer total thymocytes and signif-
icantly fewer cells in all but one of the major subpopula-
tions than the naive group, whereas such decreases were
only observed in the group with a 5 mg pellet after 24
hours (Figure 1). Similarly, the changes in subpopulation
percentages were more pronounced after 72 hours (Figure
4) than after 24 hours (Figure 2). Some of the increases in
cell number in adrenalectomized naive mice (ADX-N) or
adrenalectomized mice with a placebo pellet implanted
(ADX-P) compared to naive control that were observed in
Figure 1 were not significant in the 72 hour experiment
(Figure 3). It should be noted that these groups were
essentially equivalent in all experiments, because adrena-
lectomy occurred 3 weeks before analysis in all mice. Eval-
uation of pooled, normalized data from 4 independent
experiments indicates that compared to naive mice (100 ±
4.3%), ADX-N (143 ± 5.2%) and ADX-P (144 ± 8.3%)
groups had significantly more total thymocytes. The mean
number of nucleated cells per thymus in the naive (non-
adrenalectomized) groups was 8.1 × 107  in these 4
experiments.
Serum corticosterone concentrations indicate that 
corticosterone replacement with pellets yields appropriate 
corticosterone concentrations and that sub-physiological 
corticosterone concentrations (in ADX mice) are not 
sufficient to maintain thymus homeostasis
The serum corticosterone concentration measured in
naive mice was 185 ng/ml (Figure 5A). Normal corticos-
terone values in female B6C3F1 mice vary from less than
100 ng/ml to approximately 300 ng/ml in a circadian pat-
tern [20].
Adrenalectomized mice had barely detectable concentra-
tions of corticosterone in the serum, and corticosterone
pellets containing increasing amounts of corticosterone
produced increasing corticosterone concentrations in the
serum. These results were obtained 24 hours after implan-
tation of pellets. These serum corticosterone concentra-
tions range from values that can be found in normal
(unstressed) mice at certain times of the day [20]
(observed in groups treated with 0.5 and 1.5 mg pellets)
to values that are comparable to those measured in mice
exposed to moderately or highly stressful conditions
[20,21] (observed in mice treated with 2.5 or 5.0 mg pel-
lets). Non-linear curve fitting was used to extrapolate the
size of pellet that would be required to produce the same
corticosterone concentration measured in naive mice. The
extrapolated value (1.75 mg) is shown in Figure 5B. Thus,
the effects of adrenalectomy on the thymus should not
quite be reversed by a 1.5 mg pellet and should be more
than reversed by a 2.5 mg pellet. The results shown in Fig-
ure 3 are reasonably consistent with this expectation. It
seems appropriate to examine the 72-hour data in this
regard (Figure 3), because this exposure period most likely
represents the time required to achieve the maximum
effects of corticosterone on the thymus. The slight differ-
ences from expected effects for some subpopulations may
be related to the fact that pellets do not reproduce the cir-
cadian changes in corticosterone that occur in normal ani-
mals. These changes likely contribute to thymus
homeostasis, and restoring corticosterone to a constant
concentration may not mimic this effect precisely. Never-
theless, these results clearly demonstrate that corticoster-
one alone is able to reverse the effects of adrenalectomy
and that this reversal occurs at concentrations within
physiological levels. This suggests that corticosterone is
the only adrenal product required to regulate thymocyte
number. More importantly, these results conclusively
demonstrate that corticosterone produced in the thymus
is not sufficient to maintain normal thymocyte numbers.BMC Immunology 2004, 5:24 http://www.biomedcentral.com/1471-2172/5/24
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Effect of adrenalectomy and restoration of various concentrations of corticosterone on the number of nucleated cells in the  thymus 72 hours after implantation of corticosterone pellets Figure 3
Effect of adrenalectomy and restoration of various concentrations of corticosterone on the number of nucle-
ated cells in the thymus 72 hours after implantation of corticosterone pellets Treatment groups were: Naive, 
untreated; ADX-N, adrenalectomized naive; ADX-P, adrenalectomized with placebo pellet implanted; other groups, adrenalec-
tomized with corticosterone pellets of the indicated size implanted. The thymus was evaluated 72 hours after pellet implanta-
tion (~3–4 weeks after ADX). Group size was 5–12. Values shown are mean ± S.E. obtained by normalizing groups to the 
mean value for the Naive group (defined as 100%). Results shown are pooled from two independent experiments, and groups 
significantly different from the naive group (by ANOVA followed by Dunnett's test) are shown by * (p < 0.05) or ** (p < 0.01).BMC Immunology 2004, 5:24 http://www.biomedcentral.com/1471-2172/5/24
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Differential sensitivity of thymic subpopulations as 
indicated by linear regression analysis
It is clear that thymic subpopulations differ in their sensi-
tivity to high (stress-inducible) corticosterone concentra-
tions. However, linear regression analysis (Figure 6)
indicates that the sensitivities of the various cell popula-
tions are not as different as might be expected on the basis
of the decreased percentage of CD4+CD8+ cells and the
increased percentages of the other subpopulations. The
results demonstrate that increasing concentrations of cor-
ticosterone affect CD4-CD8- and CD4+CD8+ similarly, but
the slope for CD4+CD8+ cells is significantly greater (by
the method of Zar as implemented by Prism software)
than for CD4-CD8- cells, indicating slightly greater sensi-
tivity to high concentrations of corticosterone. The effect
of increasing concentrations of corticosterone on
CD4+CD8- cells was significantly less than the effect on
CD4+CD8+ cells with regard to the slopes of the respective
lines. The slope for CD4-CD8+ cells was less than the slope
for all other subpopulations, suggesting a lower sensitivity
of these cells to corticosterone across the whole range of
concentrations. However, the decrease for CD4+CD8- cells
and CD4-CD8+ cells relative to naive control was essen-
tially the same in mice treated with a 5 mg pellet, suggest-
ing that the difference in sensitivity is minimal as the
corticosterone concentration increases. Although non-lin-
ear models would likely have given better correlation
coefficients than linear ones for some of these data, linear
models facilitate comparison. In addition, the Runs Test
was conducted for all linear regression analyses, and the
non-linear component was not significant for any of these
data.
Role of changes in the rate of apoptosis in decreased and 
increased cell number in the thymus of ADX mice with or 
without a corticosterone pellet
There are several mechanisms by which corticosterone
might act to alter the number of cells in each subpopula-
tion in the thymus. Although induction of apoptosis is
generally regarded to be the major mechanism [1-3,22],
Figure 4
Effect of adrenalectomy and restoration of various concen- trations of corticosterone on the percentage of cells in the 4  major subpopulations in the thymus 72 hours after implanta- tion of corticosterone pellets Figure 4
Effect of adrenalectomy and restoration of various 
concentrations of corticosterone on the percentage 
of cells in the 4 major subpopulations in the thymus 
72 hours after implantation of corticosterone pellets 
Data from the experiments noted in Figure 3 were analyzed 
for changes in the percentage of each cell type as compared 
to the total number of nucleated cells per thymus. Groups 
significantly different from the naive group (by ANOVA fol-
lowed by Dunnett's test) are shown by * (p < 0.05) or ** (p < 
0.01).BMC Immunology 2004, 5:24 http://www.biomedcentral.com/1471-2172/5/24
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altering differentiation or proliferation of thymocytes,
altering the development of pro-thymocytes in the bone
marrow, or altering pro-thymocyte or thymocyte traffick-
ing to or from the thymus are all possible mechanisms. To
determine if changes in apoptosis may play a role in the
effects noted in this study, apoptosis was evaluated using
two criteria: cell size (indicated by forward scatter) and
TUNEL labelling for DNA fragmentation. As shown in Fig-
ure 7, the results demonstrate that the percentage of apop-
totic cells in the thymus was decreased in mice that had
sub-physiological concentrations of corticosterone in the
serum (ADX-naive, ADX-placebo, and ADX mice with a
0.5 mg corticosterone pellet). The percentage of apoptotic
cells was substantially increased in mice with a high
(stress-inducible) concentration of corticosterone in the
serum (caused by a 5 mg pellet).
Initially, changes in the percentage of apoptotic cells in
the various subpopulations did not seem entirely consist-
ent with the changes in the percentages of each subpopu-
lation in the thymus (compare Figure 2 and Figure 7).
Three-color flow cytometry allowed determination of the
percentage of apoptotic cells in each subpopulation. In
naive mice, most apoptotic cells were CD4+CD8+, as
expected, with a substantial percentage in the CD4-CD8-
category and lesser percentages of the mature single posi-
tive categories. The percentages of apoptosis in all
populations increased in mice treated with a 5.0 mg
Serum corticosterone concentration 24 hours after implan- tation of corticosterone pellets Figure 5
Serum corticosterone concentration 24 hours after 
implantation of corticosterone pellets Mice from one 
of the experiments noted in Figures 1 and 2 were bled prior 
to removal of the thymus, and serum corticosterone concen-
trations were determined by radioimmunoassay. In panel A, 
values shown are means ± SE (n = 5 mice/group), and values 
significantly different from the naive control are indicated by 
* (p < 0.05) or ** (p < 0.01). The treatments are described in 
the legend for Figure 1. In panel B, non-linear regression was 
used to determine a best-fit line through points from 0 
(ADX-N) to 5 mg corticosterone pellets (open squares). The 
extrapolated pellet size required to produce the same corti-
costerone concentration shown for Naive mice in panel A is 
indicated by an open circle. Dotted lines indicate the 95% 
confidence interval for the regression line. The R-squared 
value for this relationship was 0.987.
Linear regression analysis of corticosterone pellet size (mg)  and the number of cells per thymus for each of the 4 major  subpopulations Figure 6
Linear regression analysis of corticosterone pellet 
size (mg) and the number of cells per thymus for 
each of the 4 major subpopulations The thymus was 
evaluated 24 hours after pellet implantation (~3–4 weeks 
after ADX), and all groups shown were ADX. Group size 
was 5–12. Values shown are mean ± S.E. obtained by normal-
izing groups to the mean value for the Naive group (defined 
as 100%). Results shown are pooled from two independent 
experiments, and statistically significant differences in the 
slope and intercept of each pair-wise combination are 
described in the text.BMC Immunology 2004, 5:24 http://www.biomedcentral.com/1471-2172/5/24
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Apoptosis in the thymus in response to sub-physiological and stress-inducible concentrations of corticosterone Figure 7
Apoptosis in the thymus in response to sub-physiological and stress-inducible concentrations of corticosterone 
Apoptosis was evaluated using the TUNEL technique with fluorescein-labelled dUTP. The cells were also surface labelled with 
fluorescent-labelled antibodies to CD4 and CD8. Values shown represent means ± SE for groups of 5 mice. The values in the 
upper panel represent the percentage of apoptotic cells in the thymus. The other values represent the percentage of apoptotic 
cells that are within each of the major 4 subpopulations in the thymus. Groups significantly different from the naive group (by 
ANOVA followed by Dunnett's test) are shown by * (p < 0.05) or ** (p < 0.01).BMC Immunology 2004, 5:24 http://www.biomedcentral.com/1471-2172/5/24
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corticosterone pellet, except CD4+CD8+ cells, for which
the percentage decreased. This almost certainly reflects the
fact that this subpopulation was depleted by 24 hours of
elevated corticosterone concentrations (Figure 1), and at
least some of the remaining CD4+CD8+ cells were likely
glucocorticoid resistant [23]. However, it should also be
noted that an increase in apoptosis was only observed in
mice treated with a 5 mg pellet, not in mice treated with a
0.5 mg pellet. In contrast, a 0.5 mg pellet diminished the
significant increase in cell numbers caused by adrenalec-
tomy (Figure 3). This suggests the possibility that mecha-
nisms other than apoptosis may also be involved
glucocorticoid-mediated homeostasis in the thymus. The
large percentage of CD4-CD8- cells in the apoptotic popu-
lation was not entirely unexpected, because there is a
developmental checkpoint that can lead to death in CD4-
CD8- cells that do not productively rearrange a TCR β
chain [24]. In the human thymus, the percentage of apop-
totic CD4-CD8- is lower than we noted (13% in humans
vs. 34% in the present study) [25]. However, the human
thymuses in that study were obtained from newborns,
and the differences could thus reflect age as well as species
differences.
Effect of ADX with or without corticosterone pellets on 
immature single positive cells in the thymus
Single positive CD8 cells that express low levels of CD3
(and TCR) are apparently the immediate precursors for
CD4+CD8+ cells in the thymus [24]. One report indicates
that these cells are more susceptible than mature single
positive cells to glucocorticoids [19]. Results shown in
Figure 8 are consistent, at least in part, with this finding.
The increase in the percentage of this subpopulation in
mice treated with a 5 mg pellet (2.4 fold) was
substantially less than the increase in mature single posi-
tive cells (~5-fold) (Figure 2). In addition, the number of
immature CD8+ cells was decreased to a greater extent
than for mature single positive cells at this time point (Fig-
ure 1). This suggests that immature single positive cells are
more sensitive to high levels of corticosterone than
mature single positive cells, though they are apparently
less sensitive than CD4+CD8+ and CD4-CD8- cells. The
number of immature single positive cells did not increase
significantly in ADX mice that did not receive a corticos-
terone pellet, indicating that homeostasis of this cell type
is not affected by physiological levels of corticosterone.
This further illustrates that it is not appropriate to infer the
effects of physiological concentrations of glucocorticoids
on various cells types on the basis of the action of phar-
macological concentrations of glucocorticoids. The per-
centage of immature single positive cells in the thymus of
untreated mice in our study was comparable to values
noted by others [19,26].
Relationship of present results and results from other 
studies
The findings reported here are consistent with some, but
not all, results from other laboratories. The study most rel-
evant to the present one involved the use of transgenic
mice that express glucocorticoid receptor at higher than
normal or lower than normal levels [4]. Comparing
changes in the number of thymocytes in various subpop-
ulations in mice expressing twice the normal level of glu-
cocorticoid receptor in the thymus with our results at
moderately elevated corticosterone concentrations (2.5
mg pellet, figure 3) indicates some similarities and some
differences. In both studies, the total number of
thymocytes was decreased significantly. However, expres-
sion of higher levels of glucocorticoid receptor caused sig-
nificant suppression of cell numbers for CD4+CD8+, CD4-
CD8-, and CD4+CD8- cells, but not CD4-CD8+ cells [4]. In
contrast, the 2.5 mg pellet in adrenalectomized mice (a
situation that should be analogous to higher levels of glu-
cocorticoid receptors with normal corticosterone concen-
trations) caused significant decreases in cell number in
CD4+CD8+, CD4-CD8+, and CD4-CD8- cells, but not in
CD4+CD8- cells (Figure 3). In mice expressing lower than
normal levels of glucocorticoid receptor in the thymus
(due to incorporation of anti-sense DNA under the con-
trol of the lck promoter) [4], the pattern of change was
very similar to that which we observed in adrenalect-
omized mice (with no corticosterone pellet). In both
cases, the significant increases in cell number were noted
only for the CD4+CD8- and CD4+CD8+ subpopulations.
Cell number in the other two major subpopulations was
increased slightly, but not significantly.
The overall relationships between these results might be
explained by a report indicating that normal expression of
glucocorticoid receptor in the thymus is a very dynamic
process, with substantial changes in expression in differ-
ent subpopulations of cells [19]. In addition, the evidence
suggests that sensitivity of the various subpopulations to
glucocorticoids is not always strictly dependent on the
amount of glucocorticoid receptor expressed. Thus, other
factors that change during the development of T cells play
an important role in sensitivity to glucocorticoids. Caus-
ing excess production of glucocorticoid receptor in all
cells of the thymus (as in transgenic mice with an extra
glucocorticoid receptor gene, transcribed in all thymo-
cytes under the control of the lck promoter) [4] would not
be likely to produce the same differences in glucocorticoid
receptor levels among cellular subpopulations in the thy-
mus as noted in normal animals (in which glucocorticoid
receptor levels vary in different subpopulations). A por-
tion of the glucocorticoid receptor production would be
subject to the normal dynamic regulatory process, but a
portion of production (the portion under the control of
the lck promoter) would not. This may explain theBMC Immunology 2004, 5:24 http://www.biomedcentral.com/1471-2172/5/24
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Effect of sub-physiological and stress-inducible concentrations of corticosterone on immature single positive (CD8+)  thymocytes Figure 8
Effect of sub-physiological and stress-inducible concentrations of corticosterone on immature single positive 
(CD8+) thymocytes The histograms at the top of this figure illustrate the region containing cells that express low levels of 
CD3 (the larger purple peak on the histogram to the left, in which the isotope control is indicated by a green line), and the sub-
sequent analysis of those cells for CD4 and CD8. The cells in the lower right quadrant (outlined with bold lines) are 
CD3lowCD8+, immature single positive cells. The values shown in the graphs are means ± SE for groups of 5 mice representing 
either the percentage of immature single positive cells in the thymus or the total number of these cells in the thymus (obtained 
by multiplying the percentage by the total thymus cell number for each mouse). Groups significantly different from the naive 
group (by ANOVA followed by Dunnett's test) are shown by ** (p < 0.01).BMC Immunology 2004, 5:24 http://www.biomedcentral.com/1471-2172/5/24
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differences in the results obtained using transgenic mice
with elevated levels of glucocorticoid receptor [4] as com-
pared to our results using elevated corticosterone concen-
trations. However, expression of glucocorticoid receptor
anti-sense RNA in the thymus in a uniform manner [4]
seems to have produced similar results as decreased corti-
costerone concentrations (in adrenalectomized animals)
(Figs. 1,2,3,4,). This may reflect the fact that the action of
anti-sense RNA in a particular cell type would be expected
to be proportional to the amount of glucocorticoid recep-
tor expressed in that cell. Thus, the normal differences
between subpopulations with regard to glucocorticoid
sensitivity might be retained. Thus, it is not surprising that
the results with anti-sense glucocorticoid receptor trans-
genic mice are comparable to those for adrenalectomized
mice in our study with regard to the differential increase
in cell number for different subpopulations. It is not clear
why no increase in thymus cellularity or changes in sub-
populations were noted by other investigators using a
conditional knockout system to produce mice in which
the thymus contains little glucocorticoid receptor [14].
However, glucocorticoid receptor knockout mice can
express portions of the glucocorticoid receptor, which
may have unexpected functions [27]. Such contradictory
findings with transgenic approaches have been common
in this field of research (see Introduction), indicating a
useful role for classical pharmacological approaches such
as those in the present study.
The relationship between the results reported here and
results from studies on the interactions between glucocor-
ticoids and self-antigen in positive selection is not clear. A
recent study indicates that activation through the TCR
down regulates SRG3, a protein that associates with the
glucocorticoid receptor and increases sensitivity to gluco-
corticoids [28]. This has been proposed as an explanation
for the decreased sensitivity of mature single positive thy-
mocytes as compared to non-mature double positive thy-
mocytes to high concentrations of glucocorticoids.
However, as already noted, this pattern did not seem to
apply when comparing the effects of sub-physiological
and physiological concentrations of glucocorticoids, i.e.,
the CD4+CD8- cells increased to a greater extent than
CD4+CD8+ cells in mice with sub-physiological corticos-
terone concentrations. This suggests that the observed
changes in SRG3 may not account for differences in sensi-
tivity of cells in different subpopulations to physiological
concentrations of corticosterone. This leaves open the
question of what does mediate those differences and the
role (if any) of TCR signalling. It would be of interest to
explore this with TCR transgenic mice.
One study in which adrenalectomy has been used to eval-
uate the effects of glucocorticoids on cellular
subpopulations in the thymus yielded different results
than those reported here. In that study, there was no
increase in total cell number in the thymus, and there
were no changes in subpopulation percentages in adrena-
lectomized mice two weeks after adrenalectomy [18]. The
basis for the difference in this result and the results of
other studies, which indicate increased numbers of thy-
mocytes in adrenalectomized mice or rats [15-17] is not
clear. In a study in which one of the authors of the present
report (E. L. P.) was involved, there was a greater increase
in cell number in the thymus in adrenalectomized mice
than in the present study [16]. Perhaps because the overall
increase in cell number was greater, the increases in all
subpopulations were significant [16]. The age and hous-
ing conditions (and resulting environmental stress levels)
of the control group probably plays an important role in
this regard, and it would be very difficult to assure pre-
cisely the same conditions for the control group in every
case. Nevertheless, the results reported here along with
results from most other adrenalectomy studies and results
from one study using transgenic mice [4] indicate that
physiological (non-stress) concentrations of corticoster-
one normally decrease the number of cells in the thymus.
Conclusions
The results presented here do not directly demonstrate the
extent to which corticosterone contributes to death by
neglect or the extent to which it contributes to the death
of negatively selected thymocytes. The fact that both
CD4+CD8+ and CD4+CD8- cells are increased in number
in ADX mice is consistent with the idea that death by
neglect of CD4+CD8+ cells is mediated by corticosterone.
The increase in CD4+CD8- cells could be explained by the
failure of CD4+CD8+ cells to die before reaching maturity,
as they would have done in the presence of corticosterone.
The observation that CD4-CD8+ cells are not increased to
the same extent as CD4+CD8- cells is exactly what would
have been predicted if sub-physiological concentrations
of corticosterone allow survival of cells that would nor-
mally die by neglect. Whereas maturation of CD4+CD8+
cells to CD4-CD8+ cells requires MCH class I-dependent
signals, maturation to CD4+CD8- status can be MHC-
independent and apparently occurs by default [29]. Thus,
cells that are not selected positively may preferentially
mature to CD4+CD8- cells before dying by corticosterone-
mediated apoptosis. However, sub-physiological concen-
trations of corticosterone apparently allow these non-
selected cells to survive.
Methods
Animals and animal care
Female C57BL/6 × C3H F1 (B6C3F1) mice were used in
this study. Normal, adrenalectomized (ADX), and sham
adrenalectomized mice were purchased from Charles
River Labs (Wilmington, MA). The mice were allowed to
recover from shipping stress for at least two weeks beforeBMC Immunology 2004, 5:24 http://www.biomedcentral.com/1471-2172/5/24
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use in experiments, and surgery was performed approxi-
mately one week before shipping. Thus, mice were evalu-
ated at least three weeks after surgery at an age of 8–12
weeks. Mice were maintained on a 12 hour light/dark
cycle, with free access to lab chow and water, except that
ADX mice were given water with 0.9% sodium chloride.
Sentinel mice housed periodically in the same room as the
mice used in this study were negative for common adven-
titious agents and pathogens of mice. Animal care and use
was in accord with the regulation of LSU Health Sciences
Center and the NIH Guide for Care and Use of Laboratory
Animals. The animal facility in which the mice were main-
tained is approved by the American Association for
Accreditation of Laboratory Animal Care.
Implantation of timed release corticosterone pellets
Timed-release corticosterone pellets and placebo pellets
were purchased from Innovative Research of America
(Sarasota, FL). The pellets are designed to yield constant
blood levels of corticosterone for 3 weeks. Pellets were
implanted subcutaneously in the scapular area of mice
that were anesthetized with sodium pentobarbital (55
mg/kg) and inhalation of methoxyflurane, as described in
a previous study [2]. The incision was closed with a surgi-
cal staple. The entire process was conducted aseptically.
Mice were allowed to recover on a heating pad prior to
being returned to their home cages. Parameters were eval-
uated after 24 hours in two experiments and after 72
hours in a third experiment.
Preparation of cells and flow cytometry
In two experiments, mice were euthanized by CO2 inhala-
tion and the thymus was removed for analysis. In one
experiment mice were euthanized by decapitation, trunk
blood was obtained and allowed to clot, and serum was
isolated after centrifugation. The serum was used to deter-
mine corticosterone concentration, using a radioimmu-
noassay kit (Diagnostic Products Corporation, Los
Angeles, CA) as described previously [30,31]. The thymus
was then removed from each mouse. Single cell suspen-
sions were prepared in 3 ml of RPMI 1640 by pressing the
organs between the frosted ends of sterile glass micro-
scope slides, as in previous studies [1,2]. After centrifuga-
tion, the cells were resuspended in 3 ml of RPMI 1640, 20
µl samples were taken, diluted in 10 ml of Isoton II isot-
onic buffered saline (Coulter Corp., Miami, FL), and
counted using an electronic cell counter (Coulter Model
Z1). Cells were adjusted to 2 × 107 per ml, and 50 µl was
added to the wells of a 96-well V-bottom microplate. Anti-
bodies diluted in 50 µl of FACS buffer (phosphate buff-
ered saline without calcium and magnesium plus 0.1%
bovine serum albumin and 0.1% sodium azide) were
added to appropriate wells. In each experiment in which
multiple antibodies were used, controls included cells
labeled with each antibody singly, cells labeled with each
isotype control antibody singly, cells labeled with all iso-
type control antibodies together, and unlabeled cells. The
following antibodies were used: anti-CD4 (GK1.5)
labeled with phycoerythrin (PE), anti-CD8a labeled with
Cychrome, and anti-CD3 labeled with fluorescein isothi-
ocyanate (FITC). These antibodies and matching isotype
controls were obtained from BD Pharmingen. Titration of
the antibodies indicated that a 1:8 dilution of anti-CD4
and anti-CD8 and a 1:5 dilution of anti-CD3 were appro-
priate for this study. After labeling for 30 min at 4°C, the
cells were washed, fixed with 1% paraformaldehyde (EM
Sciences, Ft. Washington, PA), washed again, and resus-
pended in FACS buffer. Samples were diluted in Isoton II
(0.4 ml) for analysis. Cells were analyzed using a FACScan
flow cytometer (Becton-Dickinson). A gate was set using
forward scatter and side scatter to exclude debris, erythro-
cytes, and clumps of cells. All cells within this gate were
then analyzed for CD3, CD4, and CD8.
In some experiments, cells were labeled to detect DNA
fragmentation instead of CD3. Cells were first labeled
with anti-CD4 (phycoerythrin) and anti-CD8 (cychrome)
as described above, then the cells were fixed with 4% para-
formaldehyde (in phosphate buffered saline). A terminal
dUTP nick end labeling (TUNEL) kit from Boehringer-
Mannheim (Indianapolis, IN) with fluorescein-labeled
dUTP was used to label apoptotic cells. Flow cytometry
was used to identify apoptotic cells by two criteria. Cells
that were small (as indicated by forward scatter) and
labeled with fluorescein (indicating DNA fragmentation)
were regarded to be apoptotic.
Statistical analysis
Values significantly different from the naive (untreated)
control group were determined by analysis of variance
(ANOVA) followed by Dunnett's post hoc test. Statistical
analysis, linear regression, and non-linear regression anal-
ysis were performed using Prism 4.0 software (GraphPad,
Inc., San Diego, CA). Comparison of slope or intercept of
pairs of regression lines was done using the method of Zar
[32] as implemented by Prism software.
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